Question Bank › Operator fluency on fresh ground

Operator fluency on fresh ground

Operator fluency on fresh ground: management answers probing questions about a new driver with unhesitating operational

Calls Tested
499
Answered YES
40
Hit Rate
8%
rare by design

DexCom, Inc. (DXCM) — this company's answers

NO on the Q4 2023 call 2024-02-08 B+
The model's full reasoning — Q4 2023 call → NOWe need to determine if the transcript shows the dynamic described. The question asks about a "recently emerged positive element of the business" whose meaningful contribution began only within roughly the last few quarters. Analysts probe it, and management responds with unhesitating, granular operational command, answering follow-up questions with specific present-tense working detail, while conveying that the element's contribution is still early. We need to identify such an element. The transcript discusses several things: G7 launch, basal coverage expansion, Stelo (upcoming launch), Dexcom ONE, 15-day sensor, etc. The recently emerged positive element could be the basal (type 2 diabetes using basal insulin only) coverage expansion, which began in mid-April 2023, so within the last few quarters. Analysts ask about basal contribution, adoption, etc. Let's see if management gives granular operational detail. Analyst questions: Robbie Marcus asks about 15-day sensor and margins. That's not basal. Danielle Antalffy asks about competition. Larry Biegelsen asks about Stelo. Mathew Blackman asks about salesforce and PCP channel. Marie Thibault asks about international. Jeff Johnson asks about international and AID. Matt Taylor asks about data. Travis Steed asks about reimbursement for Stelo. Joanne Wuensch asks about guidance and margins. Matthew O'Brien asks about domestic performance and basal. Malgaret Andrew asks about non-insulin and Stelo. Jayson Bedford asks about gross margin. Bill Plovanic asks about contribution from Basal, Hypo, Intensive. Michael Polark asks about 15-day timing. Chris Pasquale asks about Dexcom ONE. Josh Jennings asks about hypo indication. Mike Kratky asks about basal penetration. Steve Lichtman asks about Stelo go-to-market. Matt Miksic asks about margins and product lines. The question specifically asks about a "recently emerged positive element" that analysts probe. The basal expansion seems to be a key recent element. Management discusses it in response to Matthew O'Brien's question about domestic acceleration. Jereme Sylvain says: "basal is a contributor, no question. As that category expands and we take share within that category, that does contribute to the overall numbers.

← Back to the full DXCM analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, when analysts probe a RECENTLY EMERGED positive element of the business — something whose meaningful contribution began only within roughly the last few quarters — does management respond with UNHESITATING, GRANULAR OPERATIONAL COMMAND: answering follow-up questions about that new element with specific, present-tense working detail (how it is actually being produced, delivered, staffed, scheduled, priced, or scaled; which kinds of counterparties are taking it and how they behave; what the company is doing this month and next to serve it) of the kind only operators deep inside a functioning activity could supply — while conveying that the element's contribution to the reported results is still early? Answer YES when the transcript shows this ONE dynamic, in whatever form fits the business: (1) the probed element is REAL AND CURRENT — actually transacting now, not a plan or pipeline; (2) it is YOUNG — new to meaningful contribution within recent quarters, per management's own framing; (3) management's answers across at least two exchanges ADD specific operational substance beyond the prepared remarks, without deflection, hedging into generalities, or retreat to talking points; and (4) management conveys, directly or plainly in substance, that most of the element's effect lies ahead of the reported numbers. Answer NO if the probed strength concerns the company's long-established core rather than something recently emerged. NO if management's answers repeat prepared points, answer specifics with generalities, or lean on vision and market size. NO if the added detail concerns only financial housekeeping (guidance arithmetic, tax, share count). NO if the element is already mature and substantially in the results. NO if the granular engagement occurs in only a single exchange. NO if the call lacks a substantive question-and-answer session. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
MCD McDonald's Corporation Q2 2024 2024-07-29 D
HCKT The Hackett Group, Inc. Q1 2024 2024-05-08 C
CTRA Coterra Energy Inc. Q1 2024 2024-05-03 A
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
WEC WEC Energy Group, Inc. Q1 2024 2024-05-01 A
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
EGP EastGroup Properties, Inc. Q4 2023 2024-02-08 B
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
TACT TransAct Technologies Incorporated Q4 2022 2023-03-08 A
WGO Winnebago Industries, Inc. Q1 2023 2022-12-16 D
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
CHE Chemed Corporation Q3 2022 2022-11-01 B+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
ALHC Alignment Healthcare, Inc. Q3 2021 2021-11-06 B+
FFWM First Foundation Inc. Q3 2021 2021-10-26 B
KNDI Kandi Technologies Group, Inc. Q2 2021 2021-08-09 F
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
AMGN Amgen Inc. Q3 2018 2018-10-30 B+
PRIM Primoris Services Corporation Q2 2018 2018-08-11 C+
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
KIM Kimco Realty Corporation Q2 2018 2018-07-26 B+
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
HLX Helix Energy Solutions Group, Inc. Q1 2018 2018-04-24 B+
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
FI Fiserv, Inc. Q4 2017 2018-02-27 C
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
GNTX Gentex Corporation Q3 2017 2017-10-20 B
BIIB Biogen Inc. Q2 2017 2017-07-25 B
AEHR Aehr Test Systems Q2 2017 2017-01-05 F
NDSN Nordson Corporation Q3 2016 2016-08-23 A
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
ESE ESCO Technologies Inc. Q2 2016 2016-05-03 A
ENLC EnLink Midstream, LLC Q4 2015 2016-02-17 C+

How the model reasoned

IRT · Q2 2018 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it. YES The transcript shows management providing unhesitating, granular operational detail on the value-add program—a recently emerged positive element whose meaningful contribution began within the last few quarters—as probed by analysts like John Massocca and Craig Kucera. They discuss specifics such as NOI growth from phase 1 rehabs in 4Q 18 (14-15% range), phase 2 as a slight drag, $4.
LTRX · Q3 2024 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.
NICE · Q4 2023 → YESThe question is about whether management shows unhesitating, granular operational command on a recently emerged positive element when analysts probe it.

More from the question bank

Demand has broadened across independent fronNew chapter with early proofSkeptical premise dismantled with receiptsProfit machinery upgraded while volume stillExternal validators convergingThe bottleneck is inside and being paid awayAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.